Branch Therapeutics, a University of Arizona startup co-founded by BIO5 members Christopher Hulme and Curtis Thorne, has received $4 million in seed funding to advance its development of targeted therapies for cancer and other diseases.

BIO5 member Mohammed Hassan is leading groundbreaking work on the development of the world's first phototransistor capable of operating at petahertz speeds under ambient conditions. Petahertz refers to a frequency of one million billion cycles per second, representing a significant leap in speed and performance.

BIO5 member Philipp Gutruf and his team at the University of Arizona have developed a new class of wearable devices designed to monitor health for longer periods without recharging.